Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Novo Nordisk B | Copenhagen | Healthcare | Pharmaceuticals | DKK 2.36T | 23.5x | 1.08 | DKK 528.80 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.9% Upside | Upgrade to Pro+ | |
H Lundbeck AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 38.20B | 13.3x | 0.32 | DKK 32.95 | 0.5% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
H Lundbeck B | Copenhagen | Healthcare | Pharmaceuticals | DKK 38.20B | 13.3x | 0.32 | DKK 39.94 | -0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 25.1% Upside | Upgrade to Pro+ | |
ALK-Abello B | Copenhagen | Healthcare | Pharmaceuticals | DKK 32.01B | 39.1x | 0.57 | DKK 144.50 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.5% Upside | Upgrade to Pro+ | |
Bavarian Nordic | Copenhagen | Healthcare | Pharmaceuticals | DKK 12.71B | 12.9x | -0.38 | DKK 163.10 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Stenocare AS | Copenhagen | Healthcare | Pharmaceuticals | DKK 8.47M | -0.2x | 0.01 | DKK 0.43 | 2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |